finasteride and Local Neoplasm Recurrence

finasteride has been researched along with Local Neoplasm Recurrence in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's7 (53.85)29.6817
2010's1 (7.69)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Ahmed, HU; Arya, M; Day, E; Dobbs, C; Dudderidge, T; Emberton, M; Fiorentino, F; McCracken, S; Prevost, AT; Reddy, D; Shah, TT; Staffurth, J; Sydes, M; Winkler, M1
Juan, YS; Lee, HY; Li, CC; Wang, CS; Wu, WJ1
Pienta, KJ; Reyes, DK1
Bañez, LL; Blake, GW; Crawford, ED; McLeod, DG; Moul, JW1
Kujala, PM; Murtola, TJ; Tammela, TL1
Tisman, G1
Barqawi, AB; Crawford, ED; Handel, L; Moul, JW; Ziada, A1
Hellerstedt, B1
Ferrari, AC; McCarron, JP; Mencher, SK; Wang, LG1
Andriole, G; Boake, R; Crawford, D; DeKernion, J; Kadmon, D; Lieber, M; Rajfer, J; Schroeder, F; Smith, J; Soloway, M1
Andriole, GL; Bhayani, SB1
Broering, JM; Carroll, PR; Grossfeld, GD; Latini, D; Lubeck, DP; Small, EJ1
Amin, P; Chen, T; Dawson, N; Engstrom, C; Hussain, A; Naslund, M1

Reviews

3 review(s) available for finasteride and Local Neoplasm Recurrence

ArticleYear
Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.
    Urology, 2003, Dec-29, Volume: 62 Suppl 1

    Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Diethylstilbestrol; Disease-Free Survival; Drug Administration Schedule; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Tosyl Compounds; Treatment Outcome

2003
Hormonal manipulation for rising PSA after radical prostatectomy.
    Seminars in urologic oncology, 1999, Volume: 17, Issue:3

    Topics: Androgen Antagonists; Anilides; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds

1999
Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.
    Urology, 2001, Volume: 58, Issue:2 Suppl 1

    Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Finasteride; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Postoperative Complications; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Treatment Outcome

2001

Trials

5 trial(s) available for finasteride and Local Neoplasm Recurrence

ArticleYear
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial.
    Contemporary clinical trials, 2020, Volume: 93

    Topics: Ablation Techniques; Androgen Antagonists; Anilides; Brachytherapy; Costs and Cost Analysis; Equivalence Trials as Topic; Finasteride; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Progression-Free Survival; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Research Design; Tosyl Compounds; United Kingdom

2020
Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up.
    BJU international, 2009, Volume: 104, Issue:3

    Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Epidemiologic Methods; Finasteride; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome

2009
Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy.
    Urology, 2003, Volume: 62, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Enzyme Inhibitors; Finasteride; Flutamide; Follow-Up Studies; Humans; Life Tables; Male; Neoplasm Recurrence, Local; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radioisotope Teletherapy; Survival Analysis; Treatment Outcome

2003
Treatment with finasteride following radical prostatectomy for prostate cancer.
    Urology, 1995, Volume: 45, Issue:3

    Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms

1995
Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results.
    Seminars in oncology, 2001, Volume: 28, Issue:4 Suppl 15

    Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Docetaxel; Finasteride; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Paclitaxel; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Taxoids; Tosyl Compounds

2001

Other Studies

5 other study(ies) available for finasteride and Local Neoplasm Recurrence

ArticleYear
5α-reductase inhibitors impact prognosis of urothelial carcinoma.
    BMC cancer, 2020, Sep-11, Volume: 20, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Aged; Carcinoma; Carcinoma, Transitional Cell; Cholestenone 5 alpha-Reductase; Dutasteride; Finasteride; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prostatic Hyperplasia; Receptors, Androgen; Taiwan; Urothelium

2020
Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer.
    Medical oncology (Northwood, London, England), 2021, Jun-05, Volume: 38, Issue:7

    Topics: Aged; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms, Castration-Resistant; Tosyl Compounds

2021
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
    The Prostate, 2013, Volume: 73, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cohort Studies; Disease-Free Survival; Dutasteride; Finasteride; Finland; Humans; Kallikreins; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quinazolines; Sulfonamides; Survival Rate; Tamsulosin

2013
Unusual anti-angiogenic effect of combined hormonal blockade.
    The Journal of urology, 2002, Volume: 168, Issue:4 Pt 1

    Topics: Aged; Angiogenesis Inhibitors; Anilides; Antineoplastic Agents, Hormonal; Capillaries; Chemotherapy, Adjuvant; Drug Therapy, Combination; Finasteride; Humans; Leuprolide; Male; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms; Skin; Telangiectasis; Tosyl Compounds; Treatment Outcome

2002
The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review.
    Oncology reports, 2004, Volume: 11, Issue:6

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergism; Enzyme Inhibitors; Finasteride; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Phosphorylation; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Tumor Cells, Cultured

2004